Wegovy

Work

by Novo Nordisk · 2021

Wegovy is a brand name for semaglutide, an anti-obesity medication developed by Novo Nordisk for chronic weight management. Administered as a weekly subcutaneous injection, it acts as a GLP-1 receptor agonist to regulate appetite and food intake.

Learn more

1 episode featuring Wegovy

This Week in Startups
Dr Mark Hyman outlines how data-driven testing is reforming patient care
As chronic illness rises, shifting from reactive symptom management to proactive, data-driven health tracking could dramatically extend human healthspan.
Sep 4, 2026 · 58 min

1 episode featuring Wegovy

Dr Mark Hyman outlines how data-driven testing is reforming patient care